About US
Contact us
-
Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?Less than a year after securing its first Chinese approval, in previously treated metastatic melanoma patients, Merck & Co.’s Keytruda has leapt ahead of Bristol-Myers Squibb’s Opdivo and nabbed2019/4/1
-
FDA approves Novartis’ oral multiple sclerosis drug MayzentNovartis has obtained approval from the US Food and Drug Administration (FDA) for its relapsing multiple sclerosis (RMS) drug Mayzent (siponimod). The approval covers indication for secondary progres2019/3/29
-
FDA approves Clarus’ Jatenzo as testosterone replacement therapyClarus Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its oral testosterone undecanoate (TU) Jatenzo for testosterone replacement therapy. The drug is indicate2019/3/29
-
AZ's Farxiga nabbed its Type 1 nod in EU. But after Zynquista's rebuff, how will it fare at FDA?AstraZeneca’s Farxiga just won European approval in Type 1 diabetes, but its prospects in the U.S. are less certain. The FDA’s rejection of Sanofi and Lexicon Pharmaceuticals’ would-be rival Zynquist2019/3/28
-
Can Novartis MS blockbuster-to-be break Mayzent break doctors’ ‘circle of denial’?Novartis officially has approval for Mayzent to treat patients with secondary progressive multiple sclerosis (SPMS). The next challenge? Getting doctors to diagnose it. The FDAgreen-lightedthe produc2019/3/28
-
Forget thinking about 'the patient.' Pharma's shifting to consumer-centric marketing insteadPharma and healthcare aren't just thinking about patients anymore. They're thinking about customers. It's a shiftsimilar to what happened in the tech world in the late ‘80s, says Scott Rabschnuk, who2019/3/27
-
AstraZeneca to cut nearly 100 jobs at U.K. site as efficiencies 'hammer' workersLess than two years after revealing a multimillion-dollar upgrade plan for its plant in Macclesfield, U.K., AstraZeneca is cutting back, slashing almost 100 jobs in what local union called a “hammer2019/3/27
-
Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unitHealth and corrections officials in Louisiana are one step closer to treating thousands of hepatitis C patients who previously haven't hadaccess to the latest drugs. The state chose Gilead Sciences’2019/3/26
-
Merck CEO Frazier has learned to 'tune out' critics, thanks to early advice from his fatherWhen Merck CEO Kenneth Frazier was a teenager growing up in inner-city Philadelphia, his father gave him the “single most important piece of advice I’ve ever been given in my entire life,” he said du2019/3/26
-
UK MHRA recalls more batches of sartan medicationThe UK Medicines and Healthcare Products Regulatory Agency (MHRA) has recalled three batches of Losartan tablets amid fears of contamination caused by N-nitroso-N-methylamino butyric acid (NMBA). The2019/3/25